{"schema_version":"1","generated_at":"2026-11-01T22:51:00.529Z","data_as_of":null,"url":"https://www.findmykol.com/kol/erin-cobain","json_url":"https://www.findmykol.com/kol/erin-cobain/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"erin-cobain","name":"Erin Cobain","credential":"MD","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"University of Michigan","institution_url":"https://www.findmykol.com/institution/university-of-michigan","city":"Ann Arbor","state":"MI","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1093949745","orcid":"0000-0001-9602-8611","openalex":"A5073567939"},"summary":"Erin Cobain is an Oncology physician affiliated with University of Michigan. OpenAlex indexes 85 publications with 1,736 citations (h-index 14); ClinicalTrials.gov lists 2 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":85,"cited_by_count":1736,"h_index":14,"latest_activity_year":2026,"source":"works"},"trials":{"count":2,"shown":3,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT06058377","title":"Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer","phase":"PHASE3","status":"RECRUITING","role":"Overall official","sponsor":"National Cancer Institute (NCI)","source_url":"https://clinicaltrials.gov/study/NCT06058377","trial_url":"https://www.findmykol.com/trial/NCT06058377"},{"nct":"NCT05996107","title":"Study of Ribociclib Administered Concurrently With Postoperative Radiation Therapy in Patients With High-Risk, HR+/HER2- Breast Cancer","phase":"PHASE1","status":"RECRUITING","role":"Overall official","sponsor":"University of Michigan Rogel Cancer Center","source_url":"https://clinicaltrials.gov/study/NCT05996107","trial_url":"https://www.findmykol.com/trial/NCT05996107"},{"nct":"NCT02455882","title":"Tissue Procurement Protocol for Patients Undergoing Treatment for Early-Stage Breast Cancer","status":"TERMINATED","role":"Overall official","sponsor":"University of Michigan","source_url":"https://clinicaltrials.gov/study/NCT02455882","trial_url":"https://www.findmykol.com/trial/NCT02455882"}],"source":"trials"},"payments":{"company_count":7,"program_years":{"first":2021,"last":null},"rows_total":13,"shown":3,"withheld":10,"rows":[{"payer":"AstraZeneca Pharmaceuticals LP","program_year":2025,"amount_usd":5860,"payment_count":5,"source_url":"https://openpaymentsdata.cms.gov/search?query=1093949745"},{"payer":"Lilly USA, LLC","program_year":2025,"amount_usd":5200,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1093949745"},{"payer":"Novartis Pharmaceuticals Corporation","program_year":2025,"amount_usd":2685.17,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1093949745"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1093949745","source":"payments"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"The Pathologic Response Evaluation and Detection in Circulating Tumor-DNA Study: Ultrasensitive Circulating Tumor-DNA Assessment of Breast Cancer Minimal Residual Disease","year":2026,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco-25-02934","status":"verified"},{"title":"Phase 1 dose-escalation trial of talazoparib in combination with belinostat in select advanced solid tumors.","year":2025,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2025.43.16_suppl.3043","status":"verified"},{"title":"Abstract RF3-04: NRG-BR004: A Randomized, Double-blind, Phase III Trial of Taxane/Trastuzumab/Pertuzumab with Atezolizumab or Placebo in First-line HER2-positive Metastatic Breast Cancer","year":2025,"journal":"Clinical Cancer Research","source_url":"https://doi.org/10.1158/1557-3265.sabcs24-rf3-04","status":"verified"},{"title":"Antibody drug conjugates treatment response score (ADC TRS) for sequencing trastuzuamb deruxtecan (T-DXd) and sacituzumab govitecan (SG) in advanced breast cancer (aBC).","year":2025,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2025.43.16_suppl.1053","status":"verified"},{"title":"Association of MammaPrint and clinical outcomes by race among 5000 individuals with HR+HER2- early stage breast cancer enrolled in FLEX.","year":2025,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2025.43.16_suppl.11147","status":"verified"}],"source":"works"},"contact":{"address_1":"1500 E MEDICAL CENTER DR FL B1","city":"Ann Arbor","state":"MI","zip":"481095000","phone":"734-936-4000","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1093949745","source":"identity"},"similar":[{"name":"Max Wicha","slug":"max-wicha","institution":"University of Michigan","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/max-wicha","json_url":"https://www.findmykol.com/kol/max-wicha/profile.json"},{"name":"Dinesh Khanna","slug":"dinesh-khanna","institution":"University of Michigan","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/dinesh-khanna","json_url":"https://www.findmykol.com/kol/dinesh-khanna/profile.json"},{"name":"Eva Feldman","slug":"eva-feldman","institution":"University of Michigan","specialty":"Neurology","url":"https://www.findmykol.com/kol/eva-feldman","json_url":"https://www.findmykol.com/kol/eva-feldman/profile.json"},{"name":"Matthias Kretzler","slug":"matthias-kretzler","institution":"University of Michigan","specialty":"Nephrology","url":"https://www.findmykol.com/kol/matthias-kretzler","json_url":"https://www.findmykol.com/kol/matthias-kretzler/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":10,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2020-04-28","provider_certified":"2020-04-28","collected_at":"2026-10-31T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}